US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

ClearPoint Neuro Inc. - Common Stock (NQ:CLPT)

10.89 -0.55 (-4.85%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ClearPoint Neuro Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Gapping stocks in Monday's session ↗
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
News headline image
Discover the top movers in Monday's pre-market session. ↗
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
ClearPoint Neuro Shares Are Trading Higher Wednesday: What's Going On? ↗
ClearPoint Neuro Inc. (NASDAQ:CLPT) shares are trading higher Wednesday after the company announced results from a Phase I-II clinical study evaluating its ClearPoint Prism Neuro Laser Therapy System. 
Via Benzinga
News headline image
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
Via ACCESS Newswire
News headline image
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket ↗
Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritten public offering of common stock and pre-funded warrants. 
Via Benzinga
News headline image
Top movers in Wednesday's session ↗
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Gapping stocks in Wednesday's session ↗
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
Via ACCESS Newswire
News headline image
ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Mixed Q2 2025 Results with Record Revenue but Narrow EPS Miss ↗
ClearPoint Neuro posts record Q2 2025 revenue of $9.2M (+17% YoY) but misses estimates. EPS at -$0.21. Stock rises slightly as company reaffirms full-year guidance amid strategic expansion. 
Via Chartmill
News headline image
ClearPoint Neuro Reports Second Quarter 2025 Results
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025
Via ACCESS Newswire
News headline image
ClearPoint Neuro Reports Q1 Earnings: Revenue Beat, EPS Miss, Company Affirms FY25 Guidance ↗
ClearPoint Neuro announces Q1 earnings, beating revenue estimates but missing earnings estimates. Company affirms full-year sales guidance. 
Via Benzinga
News headline image
ClearPoint Neuro Reports First Quarter 2025 Results
Via ACCESS Newswire
News headline image
Earnings Scheduled For August 12, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 13, 2025 ↗
 
Via Benzinga
News headline image
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing
Via ACCESS Newswire
News headline image
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room
Via ACCESS Newswire
News headline image
uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >